Bayer Yakuhin and Fuji Film RI Pharma Jointly Market Lymphoma Drug
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Bayer Yakuhin, a subsidiary of Bayer Healthcare and Tokyo-based Fuji Film RI Pharma, a subsidiary of Fuji Film announced August 4 to jointly market Sevorin, a B-cell non-Hodgkin's lymphoma drug. (Click here for more - Japanese language) "Bayer Yakuhin and Fuji Film Subsidiary Jointly Market Lymphoma Drug And Start Taking Orders" - Jiji Press (8/4/08)
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.